Profund Advisors’s Intersect ENT, Inc XENT Stock Holding History

Profund Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,329	Closed	-$297K	–	1490
2018 Q3	$297K	Buy	+10,329	New	+$310K	0.01%	1205

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Profund Advisors's XENT Position: Q4 2018 in Review

Profund Advisors sold out of Intersect ENT, Inc (XENT) in Q4 2018, closing a stake of 10,329 shares — an estimated $297K sold.

Profund Advisors first reported a position in XENT in Q3 2018 and held it in 1 quarter. The position peaked at $297K in Q3 2018. 136 funds tracked by Wall St. Rank hold XENT as of Q4 2018.

Profund Advisors reported no remaining Intersect ENT, Inc position as of Q4 2018 after selling out during the quarter.
Profund Advisors sold 10,329 Intersect ENT, Inc shares in Q4 2018, an estimated $297K.
Profund Advisors first reported a position in Intersect ENT, Inc in Q3 2018 and held it in 1 quarter.
Profund Advisors's Intersect ENT, Inc position peaked at $297K in Q3 2018.
136 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2018.

Based on Profund Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.